NCT05074303View on ClinicalTrials.gov

Beta-glucan and Immune Response to Influenza Vaccine

PHASE2CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

July 18, 2022

Primary Completion Date

March 1, 2024

Study Completion Date

August 28, 2024

Conditions
Healthy Aging
Interventions
BIOLOGICAL

Influenza Vaccine

All subjects will receive the influenza vaccine.

DIETARY_SUPPLEMENT

Beta-glucan

2 - 250 mg capsules/day of beta-glucan derived from Baker's yeast

DIETARY_SUPPLEMENT

Placebo

2 - 250 mg capsules/day of cellulose

Trial Locations (1)

32611

Food Science and Human Nutrition Department, University of Florida, Gainesville

All Listed Sponsors
collaborator

Danstar Ferment AG

UNKNOWN

lead

University of Florida

OTHER